First UK Hospital Implements Latest Siemens PET·CT Technology
Since implementation of the new technology, Castle Hill hospital has seen a rapid increase in referrals for PET·CT examinations. Replacing a mobile scanner that would visit the Trust three days a week, the new system is in action five days a week and currently imaging up to 50 patients within that time. The Biograph mCT Flow Edge will be used as an essential tool in radiation treatment planning and it is anticipated its use will be extended to dementia and cardiac imaging, two of the most prevalent disease areas in the UK.
“The Biograph mCT Flow Edge was chosen as the hospital was looking for a state-of-the-art system to conduct clinical work and high-end clinical and translational research,” states Dr Ged Avery, Consultant Radiologist at Castle Hill Hospital. “As a result of the technology, clinicians are benefitting from improved image quality and patients are receiving a reduced dose and faster service. It is considered that in the near future this will have a positive effect on reducing patient bed times and increasing throughput.”
The system overcomes the limitations of conventional bed-based PET·CT with FlowMotionTM, an innovative new technology that moves the patient smoothly through the system’s gantry, while continuously acquiring PET data. FlowMotion also expands accurate and reproducible quantification in all dimensions for precise disease characterisation in therapy monitoring, while enabling clinicians to offer as low as reasonably achievable (ALARA) dose to every patient.
Neil Lincoln, Northern Sales Manager at Siemens Healthcare states, “We are delighted to work alongside Hull and East Yorkshire Hospitals NHS Trust, The Daisy Appeal and Alliance Medical to provide the very first Biograph mCT Flow Edge in the UK. The system is providing vital support to the growing number of patients who can benefit from a PET·CT examination in the North East region. The system’s FlowMotion anatomy-based scanning approach helps enable clinicians to make a more confident diagnosis due to the high quality images produced, as well as accurate and reproducible quantification for treatment planning and monitoring.”
The Daisy Appeal funded the system with the aim to create better health outcomes for patients across the region by enabling quicker diagnosis of cancer, heart disease and dementia. The new PET-CT scanner is being operated by provider of medical imaging services, Alliance Medical.
Image credit: Wikipedia
Published on : Thu, 9 Oct 2014
Better detection. Clinically superior. Low dose.** What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies? Questions like these inspired Hologic researchers and scientists to develop Hologic...
Redefining the Vision of Cardiovascular The LISENDO 880 is Hitachi’s premium 2D/4D diagnostic ultrasound solution for cardiologists in any clinical setting. The LISENDO 880 platform is redefining the vision for cardiac ultrasound by providing exceptional...
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
The next level in usability ARIETTA 50LE is the compact entry model of the ARIETTA series, inviting easy operation from beginners through experts, taking you to the ‘next level’. This ultrasound platform combines Carefree Workflow, Clear...
About the Affirm® breast biopsy guidance system Our passion to offer innovative interventional tools that advance breast health fueled the development of the Affirm breast biopsy guidance system. This simple add-on to any Hologic 3D Mammography™-capable...